S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
TL;DR: In this article, the most prevalent cardiovascular risk factor is hypertension, which is also known as hypertension risk factor, and many people with hypertension also have comorbid conditions or risk factors for which novel treatment strategies are being tested.
Journal ArticleDOI
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed.
TL;DR: There is a strong rationale to use combinations of an ACE inhibitor or ARB plus a diuretic for management of hypertension, based on substantially increased percentages of patients achieving target BP reductions, compared with component mono-therapies.
Journal ArticleDOI
Where are we going? Beyond JNC 7.
TL;DR: On August 15, 2007, a panel discussion was held to discuss hypertension, where Suzanne Oparil,MD, University of Alabama at Birmingham, Birmingham, AL, and Thomas G. Pickering, MD, DPhil, Columbia Presbyterian Medical Center, New York, NY, spoke.
Book ChapterDOI
Hypertension in the Young
TL;DR: Despite the widespread view that primary hypertension may begin in childhood, it is frequently not possible to determine in any given case whether blood pressure increments that occur with growth are physiological or represent the origins of hypertension that will develop fully in adulthood.
Journal ArticleDOI
In Memoriam: Jiří Widimský Sr. 1925-2020.
Reinhold Kreutz,Renata Cifkova,Sverre E. Kjeldsen,Krzysztof Narkiewicz,Michel Burnier,Suzanne Oparil,Giuseppe Mancia +6 more
TL;DR: The sad news came to us of the passing of Jiři Widimský Sr. on November 11, 2020 at the age of 95 years as mentioned in this paper, this could have been expected due to the gradual deterioration of his condition in the last...